0XW Revision - Anatomical Regions, Upper Extremities ICD-10-PCS
The 0XW code range contains 49 ICD-10-PCS codes for Revision procedures on the anatomical regions, upper extremities. 48 of the codes are billable and valid for inpatient claim submission in fiscal year 2027.
Root Operation Definition
Revision: Correcting, to the extent possible, a portion of a malfunctioning device or the position of a displaced device.
Codes in the 0XW Range 49 codes · 48 billable
- 0XW Anatomical Regions, Upper Extremities, RevisionNon-billable header
- 0XW600Z Revision of Drainage Device in Right Upper Extremity, Open Approach
- 0XW603Z Revision of Infusion Device in Right Upper Extremity, Open Approach
- 0XW607Z Revision of Autologous Tissue Substitute in Right Upper Extremity, Open Approach
- 0XW60JZ Revision of Synthetic Substitute in Right Upper Extremity, Open Approach
- 0XW60KZ Revision of Nonautologous Tissue Substitute in Right Upper Extremity, Open Approach
- 0XW60YZ Revision of Other Device in Right Upper Extremity, Open Approach
- 0XW630Z Revision of Drainage Device in Right Upper Extremity, Percutaneous Approach
- 0XW633Z Revision of Infusion Device in Right Upper Extremity, Percutaneous Approach
- 0XW637Z Revision of Autologous Tissue Substitute in Right Upper Extremity, Percutaneous Approach
- 0XW63JZ Revision of Synthetic Substitute in Right Upper Extremity, Percutaneous Approach
- 0XW63KZ Revision of Nonautologous Tissue Substitute in Right Upper Extremity, Percutaneous Approach
- 0XW63YZ Revision of Other Device in Right Upper Extremity, Percutaneous Approach
- 0XW640Z Revision of Drainage Device in Right Upper Extremity, Percutaneous Endoscopic Approach
- 0XW643Z Revision of Infusion Device in Right Upper Extremity, Percutaneous Endoscopic Approach
- 0XW647Z Revision of Autologous Tissue Substitute in Right Upper Extremity, Percutaneous Endoscopic Approach
- 0XW64JZ Revision of Synthetic Substitute in Right Upper Extremity, Percutaneous Endoscopic Approach
- 0XW64KZ Revision of Nonautologous Tissue Substitute in Right Upper Extremity, Percutaneous Endoscopic Approach
- 0XW64YZ Revision of Other Device in Right Upper Extremity, Percutaneous Endoscopic Approach
- 0XW6X0Z Revision of Drainage Device in Right Upper Extremity, External Approach
- 0XW6X3Z Revision of Infusion Device in Right Upper Extremity, External Approach
- 0XW6X7Z Revision of Autologous Tissue Substitute in Right Upper Extremity, External Approach
- 0XW6XJZ Revision of Synthetic Substitute in Right Upper Extremity, External Approach
- 0XW6XKZ Revision of Nonautologous Tissue Substitute in Right Upper Extremity, External Approach
- 0XW6XYZ Revision of Other Device in Right Upper Extremity, External Approach
- 0XW700Z Revision of Drainage Device in Left Upper Extremity, Open Approach
- 0XW703Z Revision of Infusion Device in Left Upper Extremity, Open Approach
- 0XW707Z Revision of Autologous Tissue Substitute in Left Upper Extremity, Open Approach
- 0XW70JZ Revision of Synthetic Substitute in Left Upper Extremity, Open Approach
- 0XW70KZ Revision of Nonautologous Tissue Substitute in Left Upper Extremity, Open Approach
- 0XW70YZ Revision of Other Device in Left Upper Extremity, Open Approach
- 0XW730Z Revision of Drainage Device in Left Upper Extremity, Percutaneous Approach
- 0XW733Z Revision of Infusion Device in Left Upper Extremity, Percutaneous Approach
- 0XW737Z Revision of Autologous Tissue Substitute in Left Upper Extremity, Percutaneous Approach
- 0XW73JZ Revision of Synthetic Substitute in Left Upper Extremity, Percutaneous Approach
- 0XW73KZ Revision of Nonautologous Tissue Substitute in Left Upper Extremity, Percutaneous Approach
- 0XW73YZ Revision of Other Device in Left Upper Extremity, Percutaneous Approach
- 0XW740Z Revision of Drainage Device in Left Upper Extremity, Percutaneous Endoscopic Approach
- 0XW743Z Revision of Infusion Device in Left Upper Extremity, Percutaneous Endoscopic Approach
- 0XW747Z Revision of Autologous Tissue Substitute in Left Upper Extremity, Percutaneous Endoscopic Approach
- 0XW74JZ Revision of Synthetic Substitute in Left Upper Extremity, Percutaneous Endoscopic Approach
- 0XW74KZ Revision of Nonautologous Tissue Substitute in Left Upper Extremity, Percutaneous Endoscopic Approach
- 0XW74YZ Revision of Other Device in Left Upper Extremity, Percutaneous Endoscopic Approach
- 0XW7X0Z Revision of Drainage Device in Left Upper Extremity, External Approach
- 0XW7X3Z Revision of Infusion Device in Left Upper Extremity, External Approach
- 0XW7X7Z Revision of Autologous Tissue Substitute in Left Upper Extremity, External Approach
- 0XW7XJZ Revision of Synthetic Substitute in Left Upper Extremity, External Approach
- 0XW7XKZ Revision of Nonautologous Tissue Substitute in Left Upper Extremity, External Approach
- 0XW7XYZ Revision of Other Device in Left Upper Extremity, External Approach
About the 0XW Code Range
These procedures correct a malfunctioning device or reposition a displaced device in an upper extremity. The correction may involve removing or inserting a device component.
The fourth character identifies the right or left upper extremity. The fifth distinguishes open access, entry through a puncture or small incision with or without a scope, and external work. The sixth identifies a drainage device, infusion device, tissue substitute, synthetic substitute or other device. The seventh is always No Qualifier.
Questions About This Page
How many billable codes are in the 0XW range?
Of the 49 codes in this range, 48 are billable and valid for inpatient claim submission from October 1, 2026 through September 30, 2027. Table header codes group them but cannot be reported on claims.
What does the 0XW range classify?
The range classifies Revision procedures, correcting, to the extent possible, a portion of a malfunctioning device or the position of a displaced device, performed on the anatomical regions, upper extremities. Each code adds the body part, approach, device, and qualifier in characters four through seven, and links to its own reference page.
Related References
Source: CMS FY 2027 ICD-10-PCS order file and code tables, effective October 1, 2026 through September 30, 2027.
